| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/17/2011 | WO2011029633A1 Heterocyclic mglu5 antagonists |
| 03/17/2011 | WO2011029614A1 Crystalline modifications of 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol |
| 03/17/2011 | WO2011029596A1 Process for preparing 2-aminothiazol-4-yl-acetic acid derivates |
| 03/17/2011 | WO2011029554A1 Composition for prevention against spoilage by moulds and yeasts and uses and products related thereto |
| 03/17/2011 | WO2011029547A2 Pregnane derivatives condensed in the 16, 17 position with an n-substituted isoxazolidine ring as anti-inflammatory agents |
| 03/17/2011 | WO2011029537A1 Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs |
| 03/17/2011 | WO2011029460A1 Nonhygroscopic linezolid salts |
| 03/17/2011 | WO2011029415A1 Cyclobutan-1,1 -dicarboxylato complexes of platinum with n6-benzyladenine derivatives, method of their preparation and application of these complexes as drugs in antitumour therapy |
| 03/17/2011 | WO2011029404A1 Mir-125a for regulating expression of rantes, composition and use thereof |
| 03/17/2011 | WO2011029392A1 Androgen receptor antagonists and uses thereof |
| 03/17/2011 | WO2011029359A1 MEDICAMENTS CONTAINING 11β HYDROXYSTEROID DEHYDROGENASE 1 DOUBLE REGULATORS AND USES THEREOF |
| 03/17/2011 | WO2011029279A1 Fused heteroaryl compounds, preparation method and use thereof |
| 03/17/2011 | WO2011029265A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof |
| 03/17/2011 | WO2011029193A1 Method of treating cancer by inhibiting trim59 expression or activity |
| 03/17/2011 | WO2011029183A1 Composition for improving lactation |
| 03/17/2011 | WO2011029181A1 Choline fenofibrate delayed release compositions |
| 03/17/2011 | WO2011029176A1 Concentration and mental performance amplifying formulation |
| 03/17/2011 | WO2011029168A1 Compositions and methods for treating proliferative diseases |
| 03/17/2011 | WO2011008312A3 Indole and indoline derivatives and methods of use thereof |
| 03/17/2011 | WO2011006803A8 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition |
| 03/17/2011 | WO2011002953A3 Topical skin treatment kits |
| 03/17/2011 | WO2011001086A3 Use of interfering rna for treating an hiv infection |
| 03/17/2011 | WO2010144646A3 Anti-viral compounds to treat hcv infection |
| 03/17/2011 | WO2010141738A3 Compositions and method for inhibiting tumor growth |
| 03/17/2011 | WO2010132347A9 Docosahexaenoic acid for the treatment of heart failure |
| 03/17/2011 | WO2010129670A3 Method for modulating angiogenesis using fibromodulin |
| 03/17/2011 | WO2010121974A3 Catalysts and method for the hydroamination of olefins |
| 03/17/2011 | WO2010121834A3 Irak kinase family as novel target and biomarker for alzheimer |
| 03/17/2011 | WO2010120508A3 Regulation of mir-33 micrornas in the treatment of cholesterol-related disorders |
| 03/17/2011 | WO2010117194A3 Composition for preventing or treating gastric disorders containing an active component comprising a fatty acid series compound |
| 03/17/2011 | WO2010093789A8 A composition comprising (-) -trans-3- (5, 6-dihydro-4h-pyrrolo [3,2,1-ij] quinolin-1-yl)-4-(1h-indol-3-yl) pyrrolidine- 2, 5-dione in combination with a second anti-proliferative agent |
| 03/17/2011 | WO2010083414A8 Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl)-n' - (4 -fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer |
| 03/17/2011 | WO2010057449A3 A solid pharmaceutical composition with atorvastatin and telmisartan as the active substances |
| 03/17/2011 | WO2010028776A8 Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 03/17/2011 | WO2009135646A3 Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale |
| 03/17/2011 | US20110067123 Mao-b elevation as an early parkinson's disease biomarker |
| 03/17/2011 | US20110066251 Anti-angiogenic compositions and methods of use |
| 03/17/2011 | US20110066130 Abuse Potential Reduction in Abusable Substance Dosage Form |
| 03/17/2011 | US20110066101 Non-invasive ocular drug delivery |
| 03/17/2011 | US20110066100 Methods for iontophoretically treating nausea and migraine |
| 03/17/2011 | US20110065938 Method for the preparation of escitalopram |
| 03/17/2011 | US20110065806 Emollient composition for the preventive treatment of atopic dermatitis |
| 03/17/2011 | US20110065805 Xanthophyll composition containing macular pigments and a process for its preparation |
| 03/17/2011 | US20110065804 Electrodeposited metallic finishes including antimicrobial agents |
| 03/17/2011 | US20110065803 Stabilized compositions of volatile alkylating agents and methods of using thereof |
| 03/17/2011 | US20110065801 Enzymatic synthesis of sphingolipids |
| 03/17/2011 | US20110065800 Formulations for cathepsin k inhibitors |
| 03/17/2011 | US20110065799 Urokinase inhibitors, production and use thereof |
| 03/17/2011 | US20110065798 Anti-infective lubricant for medical devices and methods for preparing the same |
| 03/17/2011 | US20110065797 Deloxiglumide and proton pump inhibitors combination in the treatment of gastrointestinal disorders |
| 03/17/2011 | US20110065796 Prodrugs of guanfacine |
| 03/17/2011 | US20110065795 (1s,2s,3s,4r)-3-[(1s)-1-acetylamino-2-ethyl-butyl]-4-uanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid hydrates pharmaceutical uses thereof |
| 03/17/2011 | US20110065794 Wrinkle-preventing and improving composition |
| 03/17/2011 | US20110065793 Highly purified ethyl epa and other epa derivatives |
| 03/17/2011 | US20110065790 Latanoprost-containing aqueous pharmaceutical composition |
| 03/17/2011 | US20110065788 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate |
| 03/17/2011 | US20110065787 Therapeutic agent for male sterility |
| 03/17/2011 | US20110065786 Synthesis of rocaglamide natural products via photochemical generation of oxidopyrylium species |
| 03/17/2011 | US20110065784 Method for promoting gastrointestinal bicarbonate secretion |
| 03/17/2011 | US20110065783 Hydroxylated nebivolol metabolites |
| 03/17/2011 | US20110065782 Methods of identifying compounds that inhibit the activation of a biomolecule and methods of treatment using the compounds |
| 03/17/2011 | US20110065781 Alpha-LIPOIC ACID NANOPARTICLES AND METHODS FOR PREPARING THEREOF |
| 03/17/2011 | US20110065780 Insulin resistance improving agent |
| 03/17/2011 | US20110065779 Aav vector compositions and methods for enhanced expression of immunoglobulins using the same |
| 03/17/2011 | US20110065778 RNA Interference Mediated Inhibition of Muscarinic Colinergic Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 03/17/2011 | US20110065777 DOUBLE-STRANDED RNA (dsRNA) AND METHOD OF USE FOR INHIBITING EXPRESSION OF A FUSION GENE |
| 03/17/2011 | US20110065776 Method for Treating Hepatitis C Infection |
| 03/17/2011 | US20110065775 Compounds and methods for modulating expression of sglt2 |
| 03/17/2011 | US20110065774 Chemically modified oligonucleotides and uses thereof |
| 03/17/2011 | US20110065773 Rna interference mediating small rna molecules |
| 03/17/2011 | US20110065772 Treatment of rheumatoid arthritis |
| 03/17/2011 | US20110065771 Inflammatory bowel disease therapies |
| 03/17/2011 | US20110065770 Formulations comprising antisense nucleotides to connexins |
| 03/17/2011 | US20110065769 Transdermal delivery of ionizable drugs |
| 03/17/2011 | US20110065768 Non-steroidal androgens compounds |
| 03/17/2011 | US20110065767 Substituted CC-1065 Analogs and Their Conjugates |
| 03/17/2011 | US20110065766 Methods of use of antiviral compounds |
| 03/17/2011 | US20110065765 Angiotensin ii receptor antagonists |
| 03/17/2011 | US20110065764 5- phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators |
| 03/17/2011 | US20110065763 Compositions for Topical Application Having Androgenic Actions |
| 03/17/2011 | US20110065762 Methods of use of antiviral compounds |
| 03/17/2011 | US20110065761 Methods of treating nerve-related vision disorders |
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065759 5-(3,4-dichloro-phenyl)-n-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro-ethoxy)-nicotinamide and salts thereof |
| 03/17/2011 | US20110065758 Compositions and assays for treatment and diagnosis of helicobacter pylori infection and conditions |
| 03/17/2011 | US20110065757 Methods for treatment of kallikrein-related disorders |
| 03/17/2011 | US20110065756 Methods and compositions for treatment of obesity-related diseases |
| 03/17/2011 | US20110065755 Stable r(+)-lansoprazole amine salt and a process for preparing the same |
| 03/17/2011 | US20110065754 Iminosugars and methods of treating filoviral diseases |
| 03/17/2011 | US20110065753 Methods of treating poxviral infections |
| 03/17/2011 | US20110065752 Methods of treating orthomyxoviral infections |
| 03/17/2011 | US20110065751 Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof |
| 03/17/2011 | US20110065750 Solid Forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and Methods of Making the Same |
| 03/17/2011 | US20110065749 Method and pharmaceutical composition for treatment of mental disorders |
| 03/17/2011 | US20110065748 Compositions and methods for treating disorders of gastrointestinal motility |
| 03/17/2011 | US20110065747 Compositions and methods for treating seizure disorders |
| 03/17/2011 | US20110065746 Composition of solifenacin or salt thereof for use in solid formulation |
| 03/17/2011 | US20110065745 Polysubstituted 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, and preparation and therapeutic use thereof |
| 03/17/2011 | US20110065744 Method Of Inhibiting Mucin Secretion |
| 03/17/2011 | US20110065743 Kappa opioid receptor ligands |